Ginkgo Bioworks Holdings, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q2 2024.
  • Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $190K, a 184% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $1K.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$71K, a 99.5% increase from 2022.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was -$15M, a 915% decline from 2021.
  • Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.48M, a 178% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1K $190K +$123K +184% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$122K $31K -$51K -62.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$71K -$198K +$14.6M +98.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$14.6M -$22K +$6K +21.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$14.6M $67K +$112K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$14.8M $82K +$266K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$15M -$14.8M -$14.1M -2063% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$940K -$28K +$179K +86.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$1.12M -$45K +$386K +89.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$1.51M -$184K -$25K -15.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$1.48M -$683K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$207K -$213K -3550% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$431K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$159K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $6K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.